The phage therapy market is projected to grow at a compound annual growth rate (CAGR) of 20.50% between 2025 and 2034, according to a recent report by InsightAce Analytic. This growth is driven by increasing demand for alternative treatments to combat antibiotic-resistant bacterial infections and advancements in biotechnology.
The report highlights key market drivers, challenges, and opportunities shaping the industry landscape. Factors such as rising awareness of phage therapy’s potential and ongoing research efforts are expected to contribute to market expansion over the forecast period.
**Why this matters**
Phage therapy offers a promising solution to address the global challenge of antibiotic resistance, which poses a significant threat to public health. Understanding market trends and competitive dynamics can help stakeholders, including healthcare providers and investors, make informed decisions regarding the development and adoption of phage-based treatments.
Source: News Source